These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17329937)

  • 21. The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine prices.
    Vogler S; Zimmermann N; Habl C; Mazag J
    Cost Eff Resour Alloc; 2013 Jul; 11(1):15. PubMed ID: 23826758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Well Does a Sequential Minimal Optimization Model Perform in Predicting Medicine Prices for Procurement System?
    Pentrakan A; Yang CC; Wong WK
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34063965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient Awareness of Local Drug Price Variation and the Factors That Influence Pharmacy Choice: A Cross-sectional Survey Study.
    Brodsky SD; Awosika OD; Eleryan MG; Rengifo-Pardo M; Kuang X; Amdur RL; Ehrlich A
    J Drugs Dermatol; 2017 Dec; 16(12):1274-1280. PubMed ID: 29240864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discounting of medicines in Australian community pharmacies.
    Thai LP; Vitry AI; Moss JR
    Aust Health Rev; 2014 Nov; 38(5):517-22. PubMed ID: 25099433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do follow-on therapeutic substitutes induce price competition between hospital medicines? Evidence from the Danish hospital sector.
    Hostenkamp G
    Health Policy; 2013 Jun; 111(1):68-77. PubMed ID: 23587548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of studies reporting actual prices for medicines.
    Mardetko N; Kos M; Vogler S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Apr; 19(2):159-179. PubMed ID: 30468097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
    Rosenberg ME; Rosenberg SP
    JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price.
    Roughead EE; Kim DS; Ong B; Kemp-Casey A
    WHO South East Asia J Public Health; 2018 Sep; 7(2):99-106. PubMed ID: 30136668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Medicine Prices in New Zealand and 16 European Countries.
    Vogler S; Kilpatrick K; Babar ZU
    Value Health; 2015 Jun; 18(4):484-92. PubMed ID: 26091603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pharmaceutical price controls on the cost of cardiovascular drugs: does essentiality matter?
    Khanijo S; Kakkar AK; Kumar R; Patil AN; Bhusal G; Vishwas G; Arora G
    Expert Rev Clin Pharmacol; 2020 Jul; 13(7):797-806. PubMed ID: 32552127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
    Vogler S; Vitry A; Babar ZU
    Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.
    Iyengar S; Tay-Teo K; Vogler S; Beyer P; Wiktor S; de Joncheere K; Hill S
    PLoS Med; 2016 May; 13(5):e1002032. PubMed ID: 27243629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug pricing and value in oncology.
    Danzon PM; Taylor E
    Oncologist; 2010; 15 Suppl 1():24-31. PubMed ID: 20237214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for price reduction of HIV medicines under a monopoly situation in Brazil.
    Chaves GC; Hasenclever L; Osorio-de-Castro CG; Oliveira MA
    Rev Saude Publica; 2015; 49():. PubMed ID: 26759969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China.
    Liu C; Zhang X; Liu C; Ewen M; Zhang Z; Liu G
    BMC Health Serv Res; 2017 Aug; 17(1):597. PubMed ID: 28836974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in the costs of drugs launched in the UK between 1981 and 2015: an analysis of the launch price of drugs in five disease areas.
    Ward DJ; Doos L; Stevens A
    BMJ Open; 2019 May; 9(5):e027625. PubMed ID: 31061053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China.
    Tang Y; Liu C; Zhang X
    Appl Health Econ Health Policy; 2017 Feb; 15(1):57-64. PubMed ID: 27613726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.
    Abrha S; Tadesse E; Atey TM; Molla F; Melkam W; Masresha B; Gashaw S; Wondimu A
    BMC Pregnancy Childbirth; 2018 Nov; 18(1):464. PubMed ID: 30497441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.